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a b s t r a c t 
Objectives: We investigated whether non-pharmaceutical interventions (NPIs) reduce winter-prevalent 
respiratory viral infections represented by a respiratory syncytial virus (RSV) and influenza virus (IFV) 
during the winter in Korea. 
Methods: The Korean Influenza and Respiratory Virus Monitoring System database was used. From Jan- 
uary 2016 through January 2021, the weekly positivity of respiratory viruses and the weekly number of 
hospitalizations with acute respiratory infections were collected. The NPI period was defined as February 
2020–January 2021. We analyzed whether hospitalization and sample positivity by respiratory viruses 
changed after NPIs. Bayesian structural time–series models and Poisson analyses were used. Data from 
other countries/regions reporting positive rates of RSV and IFV were also investigated. 
Results: Compared with the pre-NPI period, the positive rates of RSV and IFV decreased significantly to 
19% and 6%, and 23% and 6% of the predicted value. Also, hospitalization significantly decreased to 9% 
and 8%, and 10% and 5% of the predicted value. The positive rates of IFV in 14 countries during the NPI 
period were almost 0, whereas sporadic outbreaks of RSV occurred in some countries. 
Conclusions: No RSV and IFV winter epidemics were observed during the 2020–2021 season in Korea. 
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious 
Diseases. 
This is an open access article under the CC BY-NC-ND license 




















Since China first reported a case of unidentified pneumonia 
o the WHO that occurred in Wuhan, Hubei Province on Decem- 
er 31, 2019, until March 16, 2021, in just 15 months, more than 
20 million confirmed cases and more than 2.7 million confirmed 
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201-9712/© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Soc
icense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) isease 2019 (COVID-19) pandemic, many countries implemented 
on-pharmaceutical interventions (NPIs) to mitigate its spread. The 
PI elements consist of social distancing, school closure, “test and 
solate” symptomatic people, hand hygiene, respiratory etiquette, 
nd environmental cleaning ( Bo et al., 2021 ). These nonspecific in- 
erventions are affecting not only COVID-19 but also several in- 
ectious diseases ( Huh et al., 2020 ). Olson SJ et al. reported that 
uring April–July 2020, when influenza is traditionally prevalent 
n the Southern Hemisphere, the influenza virus’s positive rate 
IFV) decreased dramatically from 13.7% in 2017–2019 to 0.06% in 
020 ( Olsen et al., 2020 ). Similar studies in the Northern Hemi- 
phere, including the E.U., USA, China, Taiwan, Hong Kong, Japan, 
nd Korea, also reported that these NPIs significantly reduced sev- 
ral respiratory infections ( Chan et al., 2020 , Hatoun et al., 2020 ,iety for Infectious Diseases. This is an open access article under the CC BY-NC-ND 











































































































uh et al., 2020 , Lai et al., 2020a , Lee et al., 2020 , Lei et al., 2020 ,
unagawa et al., 2021 ). 
However, existing studies have not investigated the actual win- 
er in the Northern Hemisphere due to the limitation of the 
bservation period. Also, before the winter of 2020–2021, there 
ere concerns about the co-outbreak of respiratory viral infections, 
hich are prevalent in winter, represented by a respiratory syncy- 
ial virus (RSV) and IFV ( Hills et al., 2020 , Rubin, 2020 ). This co-
utbreak with the COVID-19 pandemic might result in a consid- 
rable burden to the community since it is difficult to distinguish 
ARS-CoV2 infection from RSV or IFV, thereby leading to the pos- 
ibility of coinfection ( Rubin, 2020 ). 
Therefore, we investigated whether RSV and IFV epidemics oc- 
urred during the 2020–2021 winter in Korea, where national-level 
PIs have been implemented since February 2020. We also inves- 
igated the epidemics of other respiratory viral infections in Korea 
nd explored RSV and IFV epidemics in other countries during the 
ne year of the COVID-19 pandemic. 
ethods 
ata source in Korea 
The Korean Influenza and Respiratory Virus Monitoring System 
KINRESS) database, a nationwide active sentinel surveillance net- 
ork operated by the Korea Disease Control and Prevention Agency 
KDCA), was used. It consisted of two surveillance systems, i.e., 
pecimen-based and clinical surveillance systems. The former col- 
ects data from patients who visited outpatient clinics with acute 
espiratory infections (ARIs) at 52 participating institutions, and 
he latter collects data from patients requiring hospitalization due 
o ARI at 192 participating hospitals. These nationwide surveil- 
ance systems report the weekly number of detected cases and 
ositive rates of eight respiratory viruses (RSV, IFV, adenovirus, 
ocavirus, parainfluenza virus, rhinovirus, metapneumovirus, and 
oronavirus) using the multiplex reverse transcription-polymerase 
hain reaction (RT-PCR). In clinical surveillance, some cases diag- 
osed with rapid antigen testing (RSV and IFV only) were addi- 
ionally included. These data are accessible on the KCDA website 
 http://www.kdca.go.kr/npt/ ). 
tudy design 
This retrospective study evaluated the reduction in the posi- 
ive rate (%) and the number of hospitalizations with respiratory 
iral infections in the KINRESS database one year after imple- 
enting NPIs. We defined the preintervention period as January 
016–January 2020 (pre-NPI period) and the intervention period 
s February 2020–January 2021 (NPI period). A Bayesian structural 
ime–series model (BSTM) was used to predict the incidence in 
he NPI period from the incidence trends in the pre-NPI period. 
dditionally, we compared the observed incidence during the NPI 
eriod with the annual mean incidence during the same months 
Feb–Jan) in the pre-NPI period. We also analyzed other respira- 
ory viruses contained in KINRESS. 
ata sources from other countries/regions 
To monitor the outbreak of RSV and IFV in regions other than 
orea, 13 data samples (nation or a part of the country) based on 
entinel surveillance were collected and used for evaluation. Each 
ata sample was obtained from an international organization’s re- 
ional office or an infectious disease agency of a national health 
epartment (Supplemental Table). This study includes RSV and IFV 
onitoring data from the European regions of Northern Ireland, 
reland, England, Russia, Germany, and France. Data from Canada, 30 nited States, Mexico, Costa Rica, and Chile were used for moni- 
oring data in the Americas. Data from other regions included data 
rom Israel and Taiwan. Each surveillance system reported positive 
ates of RSV and IFV in samples collected from patients with ARI 
eekly from week 40 in 2019 to week 6 in 2021. 
tatistical analysis 
To evaluate the causal impact between the pre-NPI and NPI pe- 
iods, BSTM was used. BSTM uses synthetic control for modeling 
he counterfactual. Counterfactual is the hypothetical outcome in a 
ase where intervention had not been introduced. The causal im- 
act is obtained by evaluating the effect between the counterfac- 
ual and the actual observed outcomes. Detailed methods of BSTM 
ave been described in a previous study ( Brodersen K. H., 2015 ). 
he numerical results for the BSTM have been performed using the 
ausal impact package in R. Also, the relative risk was calculated 
sing the Poisson regression model. As the sentinel surveillance 
as not based on population-based data, crude numbers of pos- 
tive cases or positive rates were used. All tests were two-tailed, 
nd a p -value < 0.05 was considered statistically significant. Sta- 
istical analyses were performed using R v.4.0.3 (R Foundation for 
tatistical Computing, Vienna, Austria) and SAS v.9.4 (SAS Institute 
nc., Cary, NC, 
esults 
During the study period of 5 years, 53,960 positive samples in 
he specimen-based surveillance and 388,737 patient cases in clin- 
cal surveillance were identified. In the specimen-based surveil- 
ance, the mean weekly number of collected samples was 204.4 
mean; standard deviation (S.D.) ± 74.3) and, the mean weekly 
umber of hospitalized cases in the clinical surveillance was 
466.9 (mean; S.D. ± 971.0). 
urveillance of RSV and IFV in Korea 
During the 2019–2020 winter, RSV and IFV had a disease epi- 
emic that began in November–December 2019 and terminated in 
arly January 2020. Since then, these two viruses’ epidemics have 
isappeared until January 2021 (2020–2021 winter period) under 
he implementation of NPIs. ( Figure 1 and Figure 2 ) Compared 
ith the pre-NPI period, the weekly positive rate of RSV and IFV in 
he specimen-based surveillance decreased significantly from 4.1% 
nd 12.7% to 0.8% and 0.8%, respectively, resulting in an 81% and 
4% reduction in the positive rates for each virus. ( Table 1 ) More-
ver, the mean weekly number of hospitalized patients with RSV 
nd IFV in the clinical surveillance decreased significantly from 
76.3 and 297.9 to 25.3 and 22.9, respectively, resulting in a 91% 
nd 92% reduction in hospitalization for each virus. ( Table 1 ) 
In the BSTM model analysis, the observed positive rates of RSV 
nd IFV in specimen-based surveillance decreased to 23% and 6% of 
he predicted values, respectively ( p = 0.001). The observed num- 
er of hospitalized patients with RSV and IFV in the NPI period 
ecreased to 10% and 5% of the predicted number of hospitalized 
atients (both, p = 0.001) ( Table 1 ) ( Figures 1 and 2 ). 
urveillance of other respiratory viruses in Korea 
Hospitalizations with respiratory viruses other than RSV and 
FV in the NPI period decreased to 3%–26% compared to those 
n the pre-NPI period, 2%–20% of the predicted value. In the case 
f specimen-based surveillance, the positive rates of parainfluenza 
irus, metapneumovirus, and coronavirus were significantly lower 
han those in the pre-NPI period and predicted values. However, 
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Figure 1. The weekly trend of respiratory syncytial virus (RSV) from the Korean Influenza and Respiratory Virus Monitoring System, January 2016–January 2021. The solid 
lines denote the observed value, the blue-dotted lines denote the predicted value, and the gray-dotted lines denote February 2020, when the NPI began in Korea; blue shades, 
















































he positive rate of rhinovirus and bocavirus increased to 34%–
5% compared to those in the pre-NPI period, 1.34 and 2.45 times 
igher than that of the predicted values. There was no difference 
n the positive rate of adenovirus in the NPI than in the pre-NPI 
eriod. Still, it significantly decreased by 22% compared with the 
redicted value. ( Table 1 ) 
urveillance of RSV and IFV in other countries/regions ( Figure 3 ) 
During the 2019–2020 season, the RSV epidemic trend began 
–2 months earlier than the IFV epidemic. The peak of the RSV 
pidemic occurred before January 2020 in most regions, and IFV 
eaked after January 2020, except in the Southern Hemisphere, 
here seasonally, January of 2020 is summer. After the RSV epi- 
emic reached its peak, Northern Ireland, Ireland, and England had 
FV peak in December 2019. In specimens of ARIs during the 2019–
020 season, the positive rate of RSV varied from country to coun- 
ry but showed a distribution of 0%–20%. Alternatively, IFV’s pos- 
tive rate showed a 0%–60% distribution, and the positive rate of 
nfections in an epidemic period increased. The RSV epidemic has 
radually decreased and disappeared smoothly despite the imple- 
entation of NPIs to prevent COVID-19 in the spring of 2020. How- 
ver, the IFV epidemic showed a sharp decrease in the positive 
ate of specimens due to NPI’s implementation, so that the ascend- 
ng phase was gentle to the peak, while the descending phase was 
apid. In the 2020–2021 season, the positive rate of RSV varied de- 
ending on the country, but it was hardly detected. Ireland, Ger- 31 any, France, South Korea, Taiwan, Costa Rica, and Chile, which 
ntermittently reported the number of positive samples, also re- 
orted significantly lower sample positivity rates than in the previ- 
us epidemic period. However, IFV was positive in France and Rus- 
ia for only a few weeks and was not detected in most countries 
uring the 2020–2021 season. 
iscussion 
This study demonstrates that in the 2020–2021 season, the first 
inter since the NPI was implemented, the positive rates of RSV 
nd IFV in Korea and hospitalizations for these viruses were nearly 
ero by January 2021. The 2020–2021 winter is the first season 
hat had not issued an influenza season advisory since the 20 0 0–
001 season when KDCA issued a seasonal influenza advisory for 
he first time in Korea ( KCDC, 2020b ). Also, the 2020–2021 winter 
eason is the first season when there has been no RSV epidemic 
ince the KINRESS conducted PCR-based respiratory virus surveil- 
ance in 2010 ( KCDC, 2020a ). 
The implementation of NPIs in countries has significantly re- 
uced physical contact frequency, which is related to the transmis- 
ion of infectious diseases. A cross-sectional survey conducted in 
he Netherlands between April and June 2020 reported that com- 
unity contacts’ frequency decreased by 41%–76% compared with 
efore the NPI ( Backer et al., 2021 ). In the U.K., the average daily
umber of contacts also decreased to 74%, which has been re- 
orted to reduce the R0 value of SARS-CoV-2 infection from 2.6 to 
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Figure 2. The weekly trend of influenza virus (IFV) from the Korean Influenza and Respiratory Virus Monitoring System, January 2016–January 2021. The solid lines denote 
the observed value. The blue-dotted lines denote the predicted value, and the gray-dotted lines denote February 2020, when the NPI began in Korea; blue shades, 95% 










































.6 ( Jarvis et al., 2020 ). In South Korea, the rate of wearing masks
eached approximately 80%, and the daily movement of people de- 
reased up to 38% in February 2020, which was even before the 
overnment-led mandates ( Park and Yum, 2020 ). Physical distanc- 
ng and mask-wearing, along with other NPI elements, such as 
and hygiene, respiratory etiquette, and environmental cleaning, 
ay have affected the reduction of existing airborne and droplet 
ransmitted communicable infections, especially respiratory viruses 
 Chan et al., 2020 , Hatoun et al., 2020 , Huh et al., 2020 ). Our re-
ults showed that during winter, no RSV and IFV epidemic was 
ecorded in Korea in the Northern Hemisphere and during summer 
n the Southern Hemisphere ( Olsen et al., 2020 ). Also, in Korea’s 
ase, school opening was postponed until May 20, and the term 
as maintained until the end of December, showing that the trans- 
ission of respiratory viruses can also be suppressed when NPIs 
re maintained after school opening ( van den Berg et al., 2021 , 
oon et al., 2020 ). 
Interestingly, the RSV and IFV epidemic patterns after the im- 
lementation of NPIs slightly differ by country. Regarding IFV, in 
ll 14 countries included in the analysis, the positive rate of IFV 
as almost 0% after May 2020. In contrast, sporadic RSV cases 32 ere seen in countries such as Taiwan, Germany, Ireland, France, 
nd Korea. Notably, in Taiwan, one of the best countries that con- 
rolled the COVID-19 pandemic, the positive rate of RSV in Novem- 
er (week 45) 2020 was the highest at 9.6%. The infectivity of 
SV is 0.9–1.8, which is similar or slightly lower than 0.9–2.1 of 
FV, especially in adults ( Falsey and Walsh, 20 0 0 , Huang, 20 08 ,
tomaru et al., 2019 ). Therefore, it is difficult to explain this 
henomenon by the difference in the two viruses’ infectivity. Of 
ourse, there is a possibility that the sentinel surveillance systems 
n countries were not well operated compared with the pre-COVID- 
9 era, but rather, IFV appears to be almost zero in the COVID-19 
ra. Still, it is difficult to explain that only RSV is sporadic. One 
xplanation is that there is a possibility that the elements of the 
PI that specifically influence RSV and IFV epidemics are differ- 
nt ( Flaxman et al., 2020 ). As of September 2020, 156 countries, 
ncluding 14 countries in our study, required 1–2 weeks of quaran- 
ine or self-isolation for people entering the country from abroad 
egardless of symptoms ( Bielecki et al., 2020 ). This isolation pe- 
iod exceeded the incubation period of RSV (3–7 days) or IFV (1–4 
ays), and therefore, RSV or IFV influx from other countries is the- 
retically interrupted ( Lessler et al., 2009 ). 
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Figure 3. Heatmap of positive rates of (A) respiratory syncytial virus and (B) influenza virus in the national sentinel surveillance of 14 countries/regions 















































Meanwhile, the degree of NPI within each country varies. In 
articular, the domestic NPI in Taiwan is loose compared with 
ther countries due to the strict prevention of COVID-19 influx 
rom other countries ( Lai et al., 2020b ). If the origin of RSV is en-
emic and that of seasonal IFV is overseas, it may be possible to 
xplain these viruses’ different epidemic patterns. To support this 
ypothesis, further research with long-term surveillance data ac- 
ording to the degree of NPIs and research on RSV and IFV epi- 
emics in other countries, such as Vietnam and New Zealand, with 
ess domestic NPI and strict isolation of overseas entrants, is also 
equired ( Geoghegan et al., 2021 , Nguyen et al., 2021 ). 
A sharp decrease in RSV or IFV infections during the NPI period 
oes not indicate the elimination of these infections. Instead, it can 
ecrease herd immunity in the community by increasing the sus- 
eptible population to these viral infections. Baker et al . predicted 
arge-scale RSV and IFV outbreaks in the U.S. after NPI in their epi- 
emic modeling study and reported that the longer the NPI period, 
he larger the outbreak ( Baker et al., 2020 ). Therefore, monitoring 
hese transmissible infections and measures for proper prevention, 
ncluding universal vaccination and immunoprophylaxis for high- 
isk groups, needs to be continued. One of the notable findings 
f our study is that incidence reduction after NPI implementation 
aries according to respiratory viruses. In particular, the portion 
ccupied by bocavirus and rhinovirus in specimen-based surveil- 
ance increased significantly, and there was no reduction in aden- 33 virus. A similar phenomenon has recently been reported in other 
ountries. 
A surveillance study by Loren Rodgers et al. on respiratory- 
elated emergency department visits in the United States reported 
n increase in rhinovirus percent positivity in 2020 (34%) dur- 
ng the COVID-19 era compared to 2019 (26%) ( Rodgers et al., 
021 ). In addition, the decrease in adenovirus positivity was re- 
orted to be less than that in influenza, RSV, metapneumovirus, or 
arainfluenza virus. After reopening schools as part of easing the 
ockdown during the COVID-19 era, Southampton, U.K., and Hong 
ong also reported an increase in rhinovirus epidemics in schools 
 Fong et al., 2021 , Poole et al., 2020 ). It is unclear why these
iruses appear to be relatively less affected by NPIs. One hypoth- 
sis is that these non-enveloped viruses are resistant to lipophilic 
isinfectants, so it is possible that they survived longer on surfaces 
ith infectivity ( Leung, 2021 ). However, additional data are needed 
o support this hypothesis. 
There are some limitations. First, this study did not aggregate 
he total number of RSV cases and influenza in Korea. Therefore, 
ncidence rates of RSV and influenza could not be directly calcu- 
ated. However, total-case surveillance of respiratory viral infec- 
ions at the national level, which are too common and mild, is im- 
ossible. Second, the rapid antigen test was used in clinical surveil- 
ance, but the number of identified cases by rapid antigen test was 
ot presented in the surveillance. This makes it difficult to assess 
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Table 1 
The weekly positive rate (%) and weekly number of hospitalizations with respiratory viral infections in the Korean Influenza and Respiratory Virus 
Monitoring System, January 2016–January 2021 
Mean Bayesian structural time–series model Poisson regression 
(Pre-NPI period) ∗ Observed Predicted Relative effect p- 
value 
(1) 
Relative ratio ∗∗ p- 
value 
(2) 
(NPI period) † (95% CI) (95% CI) (95% CI) 
Specimen-based surveillance, %/week 
Influenza 12.69 0.80 13.36 −0.94 0.001 0.06 < .0001 









4.11 0.78 3.45 −0.77 0.001 0.19 < .0001 
(2.18, 4.61) ( −1.11, −0.40) (0.14, 0.26) 
Other Respiratory viruses 
Adenovirus 6.45 6.55 8.41 −0.22 0.017 1.02 0.80 
(6.86, 10.01) ( −0.41, −0.04) (0.90, 1.14) 
Bocavirus 2.09 5.12 3.30 0.55 0.001 2.45 < .0001 




6.62 0.09 7.07 −0.99 0.001 0.01 < .0001 
(5.68, 8.39) ( −1.17, −0.79) (0.01, 0.03) 
Rhinovirus 17.25 23.15 17.33 0.34 0.001 .34 < .0001 
(14.99, 19.65) (0.20, 0.47) (1.26, 1.43) 
Metapneumovirus 4.48 0.48 5.29 -0.91 0.001 0.11 < .0001 
(3.68, 6.83) ( −1.20, −0.61) (0.07, 0.16) 
Coronavirus 4.41 0.94 2.65 −0.64 0.001 0.21 < .0001 
Clinical surveillance, hospitalization/week 
Influenza 297.94 22.92 443.69 −0.95 0.001 0.08 < .0001 









276.27 25.25 242.77 −0.90 0.001 0.09 < .0001 
(171.48, 317.37) ( −1.20, −0.60) (0.09, 0.10) 
Other Respiratory viruses 
Adenovirus 229.95 28.37 253.64 −0.89 0.001 0.12 < .0001 
(141.50, 371.59) ( −1.35, −0.45) (0.12, 0.13) 
Bocavirus 99.74 26.02 131.47 −0.80 0.001 0.26 < .0001 




181.95 6.27 276.64 −0.98 0.001 0.03 < .0001 
(242.06, 313.15) ( −1.11, −0.85) (0.03, 0.04) 
Rhinovirus 457.80 112.25 637.97 −0.82 0.001 0.25 < .0001 
(596.47, 679.93) ( −0.89, −0.76) (0.24, 0.25) 
Metapneumovirus 108.51 7.17 156.18 −0.95 0.001 0.07 < .0001 
(118.01, 194.29) ( −1.20, −0.71) (0.06, 0.07) 
Coronavirus 104.20 25.67 132.16 −0.81 0.001 0.25 < .0001 
(104.18, 161.82) ( −1.03, −0.59) (0.23, 0.26) 
NPI = non-pharmaceutical intervention, CI = confidence interval 
∗ The pre-NPI period was defined from January 2016 to January 2020 
† The NPI period was defined from February 2020 to January 2021 































he likelihood and degree of false-positive and false-negative cases 
ue to the antigen-based method’s limitation. However, we also 
ollected and analyzed specimen-based data collected only by PCR 
nd minimized the possibility of errors in clinical monitoring data. 
hird, other factors indirectly related to NPIs, such as healthcare- 
eeking behaviors, may have increased bias. Fourth, only coun- 
ries with disclosed data on monitoring RSV and influenza-positive 
ates, even during the COVID-19 pandemic, were included in the 
tudy. Therefore, countries that do not operate national sentinel 
urveillance or have not been updated during the COVID-19 pan- 
emic were excluded from this study, so the results of this study 
ave limitations in representing the global RSV and IFV epidemics. 
Nevertheless, this study has the strength to demonstrate that 
here was no winter epidemic of RSV and IFV in the 2020–2021 
eason, which had been prevalent yearly in Korea. Further research 
s needed to determine if these declines continue into the follow- 
ng winter and how the epidemics of these viruses will change as 
he NPIs gradually ease with the introduction of COVID-19 vaccines 
n this COVID-19 era. 
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